International Conferences Conference Provider | Allan Lloyds

3rd Annual Risk Management and Pharmacovigilance Summit


After two successful Annuals, here comes the 3rd Annual Risk Management and Pharmacovigilance Summit, where you will meet and learn from the best recognized professionals within drug safety.

This year, we have on board QPPVs, VPs and Directors from companies such as Novartis, Takeda, Novo Nordisk, Gilead Sciences, Actavis, MSD, Sanofi Pasteur, UCB and many more. You will get the best advices on how to implement new GVP updates into the real world settings, how to select fit-for-purpose response strategies to growing Health Authority requests and generally, how to improve the pharmacovigilance and risk management procedures in your company. Besides, you will hear many interesting and immersive case studies on topics such as Post-Authorization Safety Studies, RMPs, Patient Support Programs, signal detection, benefit-risk assessment, globalization of pharmacovigilance, Medical Literature Monitoring, inspections preparations, digital listening and many more.

You will also find many networking and discussing opportunities there, where you will be able to exchange practical insights with other participants and pharmacovigilance/risk management experts. Save the date from 27th to 29th September and you won’t miss any news from the pharmacovigilance world in 2016.

 

Key Speakers

Susan Welsh

Chief Safety Officer

Samofi

Pilar Carrero

VP,Drug Safety/Pharmacovigilance

Novo Nordisk

Lesley Wise

VP, PV Risk Management and Pharmacoepidemiology

Takeda Pharmaceuticals

Guy Demol

AVP, EU Qualified Person for Risk Management & Pharmacovigilance

MSD

Peter De Veene

Senior VP, Head Global Drug Safety and QPPV

Grünenthal Group

Key topics

  • Updates on GVP modules
  • How to maintain a PV system globally?
  • Post-Authorisation Safety Studies - a compliance nightmare?
  • Benefit-Risk Management in the post-marketing setting
  • Medical Literature Monitoring and EMA implication
  • Pharmacovigilance Inspections Preparations
  • Change management and pharmacovigilance
  • New responsibilities in the signal management process
   

Who Should attend

This event is designed for Members of board, C-level, Senior Vice Presidents, Vice Presidents, Directors, QPPVs and Heads of departments from pharmaceutical industry involved in:

  • Pharmacovigilance
  • Drug Safety
  • Safety & Risk Management
  • Signal Detection
  • Benefit-Risk Assessment
  • Safety Evaluation
  • Regulatory Affairs, Pharmacovigilance
  • PV Governance
  • Safety Surveillance
  • Pharmacovigilance Operations
  • PV Inspection and Audit Readiness
  • Patient Support Programs
  • Market Research Programs
  • Clinical Safety
  • Medical Safety
  • Medical Information
  • Pharmacoepidemiology
  • Case Management

 

1.       Updates on GVP modules

Join us and register today

Stay on top of the latest trends

Key speakers



Key topics




Who Should Attend